Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine

被引：1
|
作者：
Capella, Dolors [1 ]
Vidal, Xavier [1 ]
机构：
[1] Hosp Univ Hebron, Serv Farmacol Clin, Barcelona 08035, Spain
来源：
AGE AND AGEING | 2007年 / 36卷 / 02期
关键词：
D O I：
10.1093/ageing/afl169
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [21] Effects of Donepezil, Galantamine and Rivastigmine in 938 Italian Patients with Alzheimer's Disease A Prospective, Observational Study
    Santoro, Aurelia
    Siviero, Paola
    Minicuci, Nadia
    Bellavista, Elena
    Mishto, Michele
    Olivieri, Fabiola
    Marchegiani, Francesca
    Chiamenti, Andrea Maria
    Benussi, Luisa
    Ghidoni, Roberta
    Nacmias, Benedetta
    Bagnoli, Silvia
    Ginestroni, Andrea
    Scarpino, Osvaldo
    Feraco, Emidio
    Gianni, Walter
    Cruciani, Guido
    Paganelli, Roberto
    Di Iorio, Angelo
    Scognamiglio, Mario
    Grimaldi, Luigi Maria Edoardo
    Gabelli, Carlo
    Sorbi, Sandro
    Binetti, Giuliano
    Crepaldi, Gaetano
    Franceschi, Claudio
    CNS DRUGS, 2010, 24 (02) : 163 - 176
  • [22] A Meta-Analysis of the Efficacy of Donepezil, Rivastigmine, Galantamine, and Memantine in Relation to Severity of Alzheimer's Disease
    Di Santo, Simona Gabriella
    Prinelli, Federica
    Adorni, Fulvio
    Caltagirone, Carlo
    Musicco, Massimo
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 35 (02) : 349 - 361
  • [23] PREDICTORS OF OUTCOME IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE TREATED WITH GALANTAMINE
    Richarz, U.
    Gaudig, M.
    Adami, M.
    Jacobs, A.
    Schreiner, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 354 - 354
  • [24] The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
    Loveman, E
    Green, C
    Kirby, J
    Takeda, A
    Picot, J
    Payne, E
    Clegg, A
    HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (01) : III - +
  • [25] First head to head study comparing the efficacy of donepezil and galantamine in Alzheimer's disease
    Soininen, H
    Martin, S
    Bullock, R
    Alhainen, K
    Hager, K
    Jones, R
    Aarsland, D
    Murthy, A
    Zhang, R
    Bahra, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S385 - S386
  • [26] DIFFERENTIAL OUTCOMES IN PATIENTS WITH ALZHEIMER'S DISEASE (AD) TREATED WITH DONEPEZIL 23
    Copher, R.
    Li, X.
    Powers, A.
    Clionsky, E.
    VALUE IN HEALTH, 2012, 15 (07) : A553 - A554
  • [27] Long term survival of patients with Alzheimer's disease with and without cerebrovascular disease treated with galantamine
    Feldman, H
    Everitt, B
    Van Baelen, B
    Kavanagh, S
    Brashear, H
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S284 - S284
  • [28] Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: A systematic review and meta-analysis
    Hansen, Richard A.
    Gartlehner, Gerald
    Webb, Aaron P.
    Morgan, Laura C.
    Moore, Charity G.
    Jonas, Daniel E.
    CLINICAL INTERVENTIONS IN AGING, 2008, 3 (02) : 211 - 225
  • [29] Donepezil in patients with severe alzheimer’s disease
    Karen Marder
    Current Neurology and Neuroscience Reports, 2006, 6 (5) : 363 - 364
  • [30] Donepezil in the treatment of patients with Alzheimer's disease
    Tsuno, Norifumi
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (05) : 591 - 598
12345